Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/BVXP stock hub

AIM/BVXP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/BVXPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

88.8M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/BVXP

In the news

Latest news · AIM/BVXP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/E12.1

P25 15.9P50 22.9P75 35.8

ROE66.6

P25 -54.2P50 2.1P75 13.7

ROIC128

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/BVXP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

GBP

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	12
Employees Change	-5%
Employees Change Percent	-29.41
Enterprise value	GBX 83.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00B4QVDF07
Last refreshed	2026-05-10
Market cap	GBX 88.8M
Price	GBX 1,678
Price currency	GBX
Rev Per Employee	1,045,194.17x
Sector	Healthcare
Sic	2836
Symbol	aim/BVXP
Website	https://www.bioventix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.37%
EV Earnings	11.23x
EV/EBIT	8.55x
EV/EBITDA	8.49x
EV/FCF	10.75x
EV/Sales	6.66x
FCF yield	8.75%
P/B ratio	8.04x
P/E ratio	12.1x
P/S ratio	7.08x
PE Ratio10 Y	24.03x
PE Ratio3 Y	18.73x
PE Ratio5 Y	21.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	77.93%
EBITDA Margin	78.45%
FCF margin	61.95%
Gross margin	92.45%
Gross Profit	GBX 11.6M
Gross Profit Growth	-2.7%
Gross Profit Growth Q	-5.4%
Gross Profit Growth3 Y	-2.94%
Gross Profit Growth5 Y	-0.66%
Net Income	GBX 7.4M
Net Income Growth	-5.21%
Net Income Growth Q	-3.91%
Net Income Growth Years	0%
Net Income Growth3 Y	-2.79%
Net Income Growth5 Y	-2.34%
Pretax Margin	78.94%
Profit Margin	59.3%
Profit Per Employee	GBX 619,761
Profitable Years	15
ROA	46.91
Roa5y	45.66
ROCE	88.52
ROE	66.64
Roe5y	64.4
ROIC	128
Roic5y	134.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.87%
Cagr15y	21.12%
Cagr1y	-34.24%
Cagr3y	-19.52%
Cagr5y	-12.2%
Div CAGR10	14.69%
Div CAGR3	-2.53%
Div CAGR5	0.27%
EPS Growth	-5.13
EPS Growth Q	-3.89
EPS Growth Years	0
EPS Growth3 Y	-2.77
EPS Growth5 Y	-2.35
FCF Growth	3.46%
FCF Growth Q	21.17%
FCF Growth3 Y	-2.29%
FCF Growth5 Y	-0.06%
OCF Growth	3.48%
OCF Growth Q	21.43%
OCF Growth10 Y	1.16%
OCF Growth3 Y	-2.21%
OCF Growth5 Y	0%
Revenue Growth	-8.21x
Revenue Growth Q	-8.52x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.68x
Revenue Growth5 Y	-0.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.96
Assets	GBX 13M
Cash	GBX 5.3M
Current Assets	GBX 12.2M
Current Liabilities	GBX 2M
Equity	GBX 11M
Liabilities	GBX 2M
Long Term Assets	GBX 837,730
Long Term Liabilities	GBX 0
Net Cash	GBX 5.3M
Net Cash By Market Cap	GBX 5.97
Net Cash Growth	3.14%
Net Debt EBITDA	GBX -0.54
Net Debt Equity	GBX -0.48
Net Debt FCF	GBX -0.68
Tangible Book Value	GBX 11M
Tangible Book Value Per Share	GBX 2.11
WACC	7.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.12
Inventory Turnover	1.48
Net Working Capital	GBX 4.9M
Quick ratio	5.76
Working Capital	GBX 10.2M
Working Capital Turnover	GBX 1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	-4.46%
Dividend Growth Years	0%
Dividend per share	GBX 1.5
Dividend Years	17
Dividend Yield	8.82%
Ex Div Date	2026-04-09
Last Dividend	GBX 0.7
Payout Frequency	Semi-Annual
Payout Ratio	105.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	156.17%
1Y total return	-34.22%
200-day SMA	1,998.8
3Y total return	-47.89%
50-day SMA	1,610.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-47.82%
All Time High	5,100
All Time High Change	-67.1%
All Time High Date	2024-02-22
All Time Low	26.51
All Time Low Change	6,230.06%
All Time Low Date	2017-11-20
ATR	96.64
Beta	0.56
Beta1y	0.61
Beta2y	0.46
Ch YTD	-11.91
High	1,708
High52	3,020
High52 Date	2025-07-01
High52ch	-44.43%
Low	1,650
Low52	1,300
Low52 Date	2026-03-23
Low52ch	29.09%
Ma50ch	4.18%
Price vs 200-day SMA	-16.04%
RSI	51.03
RSI Monthly	29.58
RSI Weekly	44.19
Sharpe ratio	-0.93x
Sortino ratio	-1.17
Total Return	8.91%
Tr YTD	-8.49
Tr15y	1,672.26%
Tr1m	2.54%
Tr1w	-2.72%
Tr3m	2.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 9.8M
Operating Income Growth	-2.98
Operating Income Growth Q	-5.98
Operating Income Growth3 Y	-2.75
Operating Income Growth5 Y	-0.6
Operating margin	77.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,139,101%
Shares Insiders	6.15%
Shares Institutions	70.17%
Shares Out	5,224,860
Shares Qo Q	0.13%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 7.7M
Average Volume	7,859.45x
Bv Per Share	2.11
CAPEX	GBX -32,753
Ch10y	62.53
Ch15y	807.1
Ch1m	-1.29
Ch1w	-2.72
Ch1y	-38.98
Ch3m	-1.29
Ch3y	-55.9
Ch5y	-59.66
Ch6m	-21.03
Change	-1.29%
Change From Open	-1.75
Close	1,700
Days Gap	0.47
Depreciation Amortization	65,275
Dollar Volume	5,589,751.1
Earnings Date	2026-06-26
EBIT	GBX 9.8M
EBITDA	GBX 9.8M
EPS	GBX 1.41
F Score	5
FCF	GBX 7.8M
FCF EV Yield	9.3x
FCF Per Share	GBX 1.49
Financing CF	-7,763,393
Fiscal Year End	June
Founded	2,003
Graham Number	817.396
Graham Upside	-51.29
Income Tax	GBX 2.5M
Investing CF	122,369
Is Primary Listing	1
Last Earnings Date	2025-12-30
Last Report Date	2025-12-31
Lynch Fair Value	GBX 703
Lynch Upside	-58.13
Ma150	1,836.4
Ma150ch	-8.62%
Ma20	1,748.8
Ma20ch	-4.04%
Net CF	161,535
Next Earnings Date	2026-06-26
Open	1,708
P FCF Ratio	11.43
P OCF Ratio	11.38
Payment Date	2026-04-24
Position In Range	48.45
Ppne	410,997
Price Date	2026-05-08
Price EBITDA	GBX 9.03
Ptbv Ratio	8.04
Relative Volume	0.38x
Revenue	12,542,330x
SBC By Revenue	0.71x
Share Based Comp	89,224
Tax By Revenue	19.64x
Tax Rate	24.88%
Tr6m	-17.97%
Volume	3,331
Z Score	45.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

AIM/BVXP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+8.8%

$1.50 annual per share

Payout ratio

+105.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+0.3%

0 consecutive years of growth

Total shareholder yield

+8.9%

Next ex-dividend date: 2026-04-09

Performance

AIM/BVXP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/BVXP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+70.2%

Share of float held by funds and institutions

Insider ownership

+6.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

AIM/BVXP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.0

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

-0.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/BVXP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/BVXP stock rating?

aim/BVXP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/BVXP analysis?

The full report lives at /stocks/aim/BVXP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/BVXP?

The latest report frames aim/BVXP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/BVXP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.